Withdrawal of immunosuppression in liver allograft recipients

This publication has 35 references indexed in Scilit:

• ROLE OF STEROID DOSE IN HYPERTENSION EARLY AFTER LIVER TRANSPLANTATION WITH TACROLIMUS (FK506) AND CYCLOSPORINE1
  Transplantation, 1996
• Incidence of rejection and infection after liver transplantation as a function of the primary disease: Possible influence of alcohol and polyclonal immunoglobulins
  Hepatology, 1996
• A RANDOMIZED PROSPECTIVE TRIAL OF STEROID WITHDRAWAL AFTER LIVER TRANSPLANTATION1,2
  Transplantation, 1995
• Corticosteroid withdrawal after liver transplantation
  Surgery, 1995
• Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection
  Hepatology, 1994
• TRENDS IN THE USE OF GLUCOCORTICOIDS IN RENAL TRANSPLANTATION
  Transplantation, 1994
• MONOTHERAPY WITH CYCLOSPORINE FOR CHRONIC IMMUNOSUPPRESSION IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS
  Transplantation, 1994
• Pulse corticosteroid therapy increases viremia (HCV RNA) in patients with chronic HCV infection . Division of Gastroenterology/Hepatology, Scripps Clinic and Research Foundation, La Jolla Ca and Chiron Corporation, Emeryville, CA
  Hepatology, 1993
• STEROID WITHDRAWAL FROM LONG-TERM IMMUNOSUPPRESSION IN LIVER ALLOGRAFT RECIPIENTS
  Transplantation, 1993
• Rejection in Liver Transplantation
  Hepatology, 1989